Skip to main content
. 2018 Jan 1;9(2):269–274. doi: 10.7150/jca.21774

Table 2.

Association of CYP1B1 SNPs with PCa Risk

SNP Cases, No. (%)
n = 1015
Controls, No. (%)
n = 1052
OR (95% CI) Pa
rs9341266
GG 774 (76.3) 816 (77.6) 1.00
AG 218(21.5) 215 (20.4) 1.07 (0.87-1.32) 0.533
AA 23 (2.3) 21 (2.0) 1.15 (0.63-2.10) 0.649
AG/AA vs. GG 1.08 (0.88-1.32) 0.477
GG/AG vs. AA 1.13 (0.62-2.06) 0.683
rs162549
TT 787 (77.5) 811 (77.1) 1.00
AT 209 (20.6) 222 (21.1) 0.95 (0.77-1.18) 0.636
AA 19 (1.9) 19 (1.8) 1.01 (0.53-1.93) 0.971
AT/AA vs. TT 0.96 (0.78-1.17) 0.660
TT/AT vs. AA 1.02 (0.54-1.95) 0.944
rs10916
TT 808 (79.6) 856 (81.4) 1.00
GT 192 (18.9) 183 (17.4) 1.12 (0.89-1.40) 0.333
GG 15 (1.5) 13 (1.2) 0.75 (0.50-1.11) 0.152
GT/GG vs. TT 1.13 (0.91-1.40) 0.289
TT/GT vs. GG 1.21 (0.57-2.56) 0.617
rs162562
AA 695 (68.5) 711 (67.6) 1.00
AC 287 (28.3) 305 (29.0) 0.97 (0.80-1.17) 0.719
CC 33 (3.3) 36 (3.4) 0.96 (0.59-1.55) 0.854
AC/CC vs. AA 0.96 (0.80-1.16) 0.700
CC/AC vs.CC 0.97 (0.60-1.56) 0.887
rs2551188
CC 541 (53.3) 558 (53.0) 1.00
CT 423 (41.7) 421 (40.0) 1.05 (0.88-1.26) 0.564
TT 51 (5.0) 73 (6.9) 0.72 (0.49-1.05) 0.086
CT/TT vs. CC 1.00 (0.84-1.19) 0.964
CC/CT vs.TT 0.70 (0.49-1.02) 0.060
rs9341250
CC 955 (94.1) 985 (93.6) 1.00
AC 58 (5.7) 64 (6.1) 0.96 (0.66-1.38) 0.806
AA 2 (0.2) 3 (0.3) 0.66 (0.11-3.94) 0.644
AC/AA vs. CC 0.94 (0.66-1.35) 0.741
CC/AC vs. AA 0.66 (0.11-3.95) 0.646
rs1056827
CC 668 (65.8) 679 (64.5) 1.00
AC 303 (29.9) 327 (31.1) 0.94 (0.78-1.14) 0.543
AA 44 (4.3) 46 (4.4) 0.98 (0.64-1.50) 0.908
AC/AA vs. CC 0.95 (0.79-1.14) 0.555
CC/AC vs. AA 0.99 (0.65-1.52) 0.976
rs1056836
CC 728 (71.7) 705 (67.0) 1.00
CG 274 (27.0) 323 (30.7) 0.82 (0.68-0.99) 0.041
GG 13 (1.3) 24 (2.3) 0.54 (0.27-1.07) 0.079
CG/GG vs. CC 0.80 (0.66-0.97) 0.020
CC/CG vs. GG 0.57 (0.29-1.14) 0.111

HWE: Hardy-Weinberg equilibrium. aAdjusted for age and smoking status.

The results were in bold if P < 0.05.